Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration
Neuron · 2023-07 · 111 (13) · 2021-2037.e12
DOI: 10.1016/j.neuron.2023.04.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2023-07. Verfasst von Beatrice Paola Festa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Cambridge Institute for Medical Research (CIMR), CB2 0XY Cambridge, UK; UK Dementia Research Institute, Cambridge Ins…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Huntington Disease. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Department of Health.
Abstract (Originalsprache)
In neurodegenerative diseases, microglia switch to an activated state, which results in excessive secretion of pro-inflammatory factors. Our work aims to investigate how this paracrine signaling affects neuronal function. Here, we show that activated microglia mediate non-cell-autonomous inhibition of neuronal autophagy, a degradative pathway critical for the removal of toxic, aggregate-prone proteins accumulating in neurodegenerative diseases. We found that the microglial-derived CCL-3/-4/-5 bind and activate neuronal CCR5, which in turn promotes mTORC1 activation and disrupts autophagy and aggregate-prone protein clearance. CCR5 and its cognate chemokines are upregulated in the brains of pre-manifesting mouse models for Huntington's disease (HD) and tauopathy, suggesting a pathological role of this microglia-neuronal axis in the early phases of these diseases. CCR5 upregulation is self-sustaining, as CCL5-CCR5 autophagy inhibition impairs CCR5 degradation itself. Finally, pharmacological or genetic inhibition of CCR5 rescues mTORC1 hyperactivation and autophagy dysfunction, which ameliorates HD and tau pathologies in mouse models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Cambridge Institute for Medical Research (CIMR), CB2 0XY Cambridge, UK; UK Dementia Research Institute, Cambridge Institute for Medical Research (CIMR), CB2 0XY Cambridge, UK.
- Department of Medical Genetics, Cambridge Institute for Medical Research (CIMR), CB2 0XY Cambridge, UK.
- Department of Medical Genetics, Cambridge Institute for Medical Research (CIMR), CB2 0XY Cambridge, UK; UK Dementia Research Institute, Cambridge Institute for Medical Research (CIMR), CB2 0XY Cambridge, UK. Electronic…
Förderung
- Medical Research Council
- Wellcome Trust
- Department of Health
- European Union
- H2020 Marie Skłodowska-Curie Actions
- Alzheimer’s Research UK
- Tau Consortium
- Institut Pasteur
Zitieren
APA
Festa, B. P., Siddiqi, F. H., Jimenez-Sanchez, M., Won, H., Rob, M., Djajadikerta, A., Stamatakou, E., & Rubinsztein, D. C. (2023). Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration. Neuron, 111(13), 2021-2037.e12. https://doi.org/10.1016/j.neuron.2023.04.006
Vancouver
Festa BP, Siddiqi FH, Jimenez-Sanchez M, Won H, Rob M, Djajadikerta A, et al. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration. Neuron. 2023;111(13):2021-2037.e12. doi:10.1016/j.neuron.2023.04.006
BibTeX
@article{Festa2023,
author = {Festa, Beatrice Paola and Siddiqi, Farah H and Jimenez-Sanchez, Maria and Won, Hyeran and Rob, Matea and Djajadikerta, Alvin and Stamatakou, Eleanna and Rubinsztein, David C},
title = {Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration},
journal = {Neuron},
year = {2023},
volume = {111},
number = {13},
pages = {2021--2037.e12},
doi = {10.1016/j.neuron.2023.04.006}
}
EUVIMED